154 related articles for article (PubMed ID: 7528164)
1. Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and "squamous differentiation" in human endometrial carcinoma.
Santini D; Ceccarelli C; Martinelli GN; Leone O; Marabini A; Orlandi C; Mancini AM
Hum Pathol; 1994 Dec; 25(12):1319-23. PubMed ID: 7528164
[TBL] [Abstract][Full Text] [Related]
2. Multidirectional differentiation of endometrial carcinoma with special reference to tumor aggressiveness evaluated by Ki-67 expression.
Ikawa S; Sano T; Furumoto H; Aono T
Gynecol Oncol; 1999 Mar; 72(3):323-30. PubMed ID: 10053102
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
Reinartz JJ; George E; Lindgren BR; Niehans GA
Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor expression and endometrial cancer histotypes.
Jasonni VM; Santini D; Amadori A; Ceccarelli C; Naldi S
Ann N Y Acad Sci; 1994 Sep; 734():298-305. PubMed ID: 7978930
[TBL] [Abstract][Full Text] [Related]
6. Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder.
Tungekar MF; Linehan J
J Clin Pathol; 1998 Aug; 51(8):583-7. PubMed ID: 9828815
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of estradiol, epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor in endometrial neoplasia.
Yokoyama Y; Takahashi Y; Hashimoto M; Morishita S; Tamaya T
Jpn J Clin Oncol; 1996 Dec; 26(6):411-6. PubMed ID: 9001345
[TBL] [Abstract][Full Text] [Related]
8. TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression.
Lee CS; Redshaw A; Boag G
Aust N Z J Surg; 1996 Jul; 66(7):464-8. PubMed ID: 8678876
[TBL] [Abstract][Full Text] [Related]
9. Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications.
Celikel C; Eren F; Gulluoglu B; Bekiroglu N; Turhal S
Pathol Oncol Res; 2007; 13(3):215-26. PubMed ID: 17922051
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
[TBL] [Abstract][Full Text] [Related]
11. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
12. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas.
Ibrahim SO; Lillehaug JR; Johannessen AC; Liavaag PG; Nilsen R; Vasstrand EN
Oral Oncol; 1999 May; 35(3):302-13. PubMed ID: 10621852
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation.
Iihara K; Shiozaki H; Tahara H; Kobayashi K; Inoue M; Tamura S; Miyata M; Oka H; Doki Y; Mori T
Cancer; 1993 May; 71(10):2902-9. PubMed ID: 8490817
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha is independent of ras mutations in lung adenocarcinoma.
Hsieh ET; Shepherd FA; Tsao MS
Lung Cancer; 2000 Aug; 29(2):151-7. PubMed ID: 10963846
[TBL] [Abstract][Full Text] [Related]
15. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region.
Wu M; Putti TC; Bhuiya TA
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):351-6. PubMed ID: 12607604
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and mixed epithelial tumors of the endometrium.
O'Leary JJ; Landers RJ; Crowley M; Healy I; O'Donovan M; Healy V; Kealy WF; Hogan J; Doyle CT
Hum Pathol; 1998 Apr; 29(4):383-9. PubMed ID: 9563789
[TBL] [Abstract][Full Text] [Related]
17. Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells.
Hata H; Hamano M; Watanabe J; Kuramoto H
Oncology; 1998 Dec; 55 Suppl 1():35-44. PubMed ID: 9852400
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix.
Konishi I; Ishikawa Y; Wang SY; Wang DP; Koshiyama M; Mandai M; Komatsu T; Yamamoto S; Mori T
Br J Obstet Gynaecol; 1994 Apr; 101(4):325-9. PubMed ID: 8199079
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids.
Krishnamurthy S; Dayal Y
Am J Surg Pathol; 1997 Mar; 21(3):327-33. PubMed ID: 9060603
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGFA) expression in different endometrial cancers.
Jasonni VM; Amadori A; Santini D; Ceccarelli C; Naldi S; Flamigni C
Anticancer Res; 1995; 15(4):1327-32. PubMed ID: 7654016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
